Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine

scientific article published on November 2013

Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/JOIM.12117
P698PubMed publication ID24127940
P5875ResearchGate publication ID257837432

P50authorMartin Hrabě de AngelisQ28606776
Gabriele MöllerQ38549034
Anna HalamaQ57335813
P2093author name stringJ Adamski
N Riesen
P2860cites workThe human serum metabolomeQ21135549
Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serumQ21145030
Discovery of sexual dimorphisms in metabolic and genetic biomarkersQ21563382
Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networksQ24646495
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionQ24654019
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysQ25939005
Metabolomics and cardiovascular biomarker discoveryQ26991473
The Chemical Translation Service--a web-based tool to improve standardization of metabolomic reportsQ27062596
Human metabolic individuality in biomedical and pharmaceutical researchQ28247002
Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycleQ28268021
Metabolic profiles of cancer cellsQ28269762
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significanceQ28279396
Metabolomic profiling of drug responses in acute myeloid leukaemia cell linesQ28474545
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataQ29784220
Normal human lymphocytes exhibit a wide range of methionine-dependency which is related to altered cell division but not micronucleus frequencyQ30663211
Metabolomics using 1H-NMR of apoptosis and Necrosis in HL60 leukemia cells: differences between the two types of cell death and independence from the stimulus of apoptosis usedQ33316515
Metabolite profiling of fecal water extracts from human colorectal cancerQ33384170
Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA studyQ33389830
Systems biologists seek fuller integration of systems biology approaches in new cancer research programsQ33575940
metaP-server: a web-based metabolomics data analysis toolQ33714742
Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approachQ33941155
A genome-wide perspective of genetic variation in human metabolismQ34090221
The dynamic range of the human metabolome revealed by challengesQ34198882
Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newbornsQ34272296
Bayesian independent component analysis recovers pathway signatures from blood metabolomics dataQ34309110
A novel serum metabolomics-based diagnostic approach for colorectal cancerQ34336333
Noninvasive real-time imaging of apoptosisQ34429029
Evidence for an alternative glycolytic pathway in rapidly proliferating cellsQ34535762
Cancer. Systems biology, metabolomics, and cancer metabolismQ34638564
Serum amino acid profiles and their alterations in colorectal cancerQ34660782
Mass spectrometry: from proteomics to metabolomics and lipidomicsQ34988633
Extending biochemical databases by metabolomic surveysQ35084955
Monitoring apoptosis and neuronal degeneration by real-time detection of phosphatidylserine externalization using a polarity-sensitive indicator of viability and apoptosis.Q35121508
Opportunities for studying cancer by metabolomics: preliminary observations on tumors deficient in hypoxia-inducible factor 1.Q35147420
Application of metabolomics to prostate cancerQ35234286
Protein biomarkers for the early detection of breast cancerQ35367572
Apoptosis in the development and treatment of cancerQ35890843
Glycomics: a pathway to a class of new and improved therapeuticsQ35906116
Genome-wide association studies with metabolomicsQ36245152
Novel biomarkers for pre-diabetes identified by metabolomicsQ36321634
Apoptosis: a basic biological phenomenon with wide-ranging implications in human diseaseQ36325036
Human serum metabolic profiles are age dependentQ36498753
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosisQ36620298
Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnoverQ36942649
Clinical applications of metabolomics in oncology: a reviewQ37177549
From differentiating metabolites to biomarkersQ37412408
Effects of sample handling and storage on quantitative lipid analysis in human serumQ37478161
Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunctionQ37582618
Rapid changes in specific estrogen binding elicited by cGMP or cAMP in cytosol from human endometrial cellsQ37610054
Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosisQ37699692
Challenges in mass spectrometry based targeted metabolomicsQ37701481
Molecular epidemiology and its current clinical use in cancer managementQ37722954
Molecular recognition mechanisms for detecting cell death in vivoQ37760227
Cell culture metabolomics: applications and future directionsQ37769930
Targeted metabolomics for biomarker discovery.Q37772442
Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effectQ37783380
Metabolomics and bladder cancerQ37935192
Metabolomics: a revolution for novel cancer marker identificationQ37973424
Nutrigenomics: implications for breast and colon cancer preventionQ37987513
Metabolomics in cancer: a bench-to-bedside intersectionQ37994896
Novel methodologies in metabolic profiling with a focus on molecular diagnostic applicationsQ38019000
The kynurenine pathway in brain tumor pathogenesis.Q38059195
Regulation of the metabolite profile by an APC gene mutation in colorectal cancerQ39387564
An in vitro investigation of metabolically sensitive biomarkers in breast cancer progressionQ39439986
Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testingQ39547930
Metabolic signatures in apoptotic human cancer cell linesQ39589801
Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancerQ39672706
Metabolic signatures of malignant progression in prostate epithelial cells.Q39679748
Characterization of 1H NMR detectable mobile lipids in cells from human adenocarcinomas.Q39884998
Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiationQ40310696
Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells.Q40428146
Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer's diseaseQ41661052
Standards, databases, and modeling tools in systems biologyQ42681438
Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1Q42729073
Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomicsQ43265820
Metabotyping of biofluids reveals stress-based differences in gut permeability in healthy individualsQ43279696
5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 geneQ44674846
Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosomeQ44978497
A metabolomic approach to lung cancerQ45297639
A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's diseaseQ47401613
Estrogens, enzyme variants, and breast cancer: a risk model.Q51933161
BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer.Q53542028
Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells: role of P36.Q54413378
Assay Tools for MetabolomicsQ59157152
Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomicsQ59157191
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectbiomarkerQ864574
metabolomicsQ12149006
P304page(s)425-439
P577publication date2013-11-01
P1433published inJournal of Internal MedicineQ6295387
P1476titleIdentification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine
P478volume274

Reverse relations

cites work (P2860)
Q26772073Blood transcriptomics and metabolomics for personalized medicine
Q50973215Change of the metabolomic profile during short-term mononuclear cell storage.
Q33745104Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls
Q90588753Decoding the metabolic landscape of pathophysiological stress-induced cell death in anucleate red blood cells
Q92645779Differential diagnosis between hepatocellular carcinoma and cirrhosis by serum amino acids and acylcarnitines
Q38787802Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway
Q38698193Experimental design and reporting standards for metabolomics studies of mammalian cell lines
Q39044824Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation
Q33707386Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage
Q52366931IntLIM: integration using linear models of metabolomics and gene expression data.
Q64101021Investigating the deregulation of metabolic tasks via Minimum Network Enrichment Analysis (MiNEA) as applied to nonalcoholic fatty liver disease using mouse and human omics data
Q93017936LC-MS metabolomics comparisons of cancer cell and macrophage responses to methotrexate and polymer-encapsulated methotrexate
Q44539143Lessons learned and challenges posed in cancer genetics. Introduction
Q34091261Long term conservation of human metabolic phenotypes and link to heritability
Q33738817Metabolic characterization of invaded cells of the pancreatic cancer cell line, PANC-1.
Q35844833Metabolic signatures differentiate ovarian from colon cancer cell lines
Q34671698Metabolomics identifies the intersection of phosphoethanolamine with menaquinone-triggered apoptosis in an in vitro model of leukemia
Q50090010Metabolomics toward personalized medicine.
Q47111053Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach.
Q47106277Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells
Q57523698Optimisation of in vitro sample preparation for LC-MS metabolomics applications on HepaRG cell cultures
Q35096373Perioperative dynamics and significance of amino acid profiles in patients with cancer
Q38826371Programmed cell death in periodontitis: recent advances and future perspectives
Q58778499Urea influences amino acid turnover in bovine cumulus-oocyte complexes, cumulus cells and denuded oocytes, and affects in vitro fertilization outcome
Q36109560Urine metabolomic profiling of children with respiratory tract infections in the emergency department: a pilot study

Search more.